Current Pharmaceutical Design

William A. Banks  
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108


Antiviral Drug Discovery Targeting to Viral Proteases

Author(s): John T. A. Hsu, Hsiang-Ching Wang, Guang-Wu Chen and Shin-Ru Shih

Affiliation: Department of Medical Biotechnology&Laboratory Science, Chang Gung University, 259 Wen-Hua1st Rd., Kwei-Shan, Tao-Yuan, Taiwan.


Proteases fulfill multiple roles in health and disease, and considerable interest has been expressed in the design and development of synthetic inhibitors of disease-related proteases. Virus-encoded proteases have been shown to be involved in the replication of many viruses. The success of anti-HIV-1 therapy using specific and potent protease inhibitors suggests that viral proteases can be the valid molecular targets for the development of antiviral drugs against other viruses. Intensive genetic and biochemical studies have been conducted on viral proteases and new insights and results are rapidly emerging. This work reviews features of viral proteases with respective to the development of effective antiviral therapy.

Keywords: Drug discovery, Viral Protease

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [1301 - 1314]
Pages: 14
DOI: 10.2174/138161206776361110
Price: $58